29EF Chervoneva, Inna - Thomas Jefferson University - Thomas Jefferson University

Inna Chervoneva, PhD

Contact Dr. Chervoneva

1015 Chestnut Street
Suite M-100 Mezzanine
Philadelphia, PA 19107

(215) 955-4083
(215) 503-3804 fax

Most Recent Peer-reviewed Publications

  1. Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases
  2. A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease
  3. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
  4. Robust estimation of the parameters of g-and-h distributions, with applications to outlier detection
  5. Generalized S-estimators for linear mixed effects models
  6. Estimation of nonlinear differential equation model for glucose-insulin dynamics in type I diabetic patients using generalized smoothing
  7. Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty
  8. Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment
  9. Analyzing the ingredients of a telephone counseling intervention for traumatic brain injury
  10. Two-stage hierarchical modeling for analysis of subpopulations in conditional distributions
  11. Conversion from enzyme-inducing antiepileptic drugs to topiramate: Effects on lipids and c-reactive protein
  12. Erratum: Major and minor depression after traumatic brain injury (Archives of Physical Medicine and Rehabilitation (2011) 92 (1211-1219))
  13. Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma
  14. Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone
  15. The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
  16. Major and minor depression after traumatic brain injury
  17. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
  18. Constrained S-estimators for linear mixed effects models with covariance components
  19. A phase i trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate cancer: First report of a completed study
  20. Latency to first seizure after temporal lobectomy predicts long-term outcome